financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Raises Opinion On 'a' Shares Of News Corporation To Buy From Hold
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Raises Opinion On 'a' Shares Of News Corporation To Buy From Hold
May 10, 2024 4:41 AM

07:15 AM EDT, 05/10/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our 12-month target by $2 to $29, on FY 25 (Jun.) EV/EBITDA of 11.1x, above NWSA's 5-year average forward EV/EBITDA of 9.8x. We cut FY 24 EPS to $0.74 from $0.76 but raise FY 25 EPS to $0.99 from $0.95. NWSA posts Mar-Q adj-EPS of $0.11, $0.02 below consensus. Revenue of $2,423M (-1% Y/Y) was $25M above consensus. Adj-EBITDA rose 0.6% Y/Y to $322M, in line with consensus, with margin widening to 13.3%. Every NWSA segment, excluding Real Estate and Dow Jones, experienced revenue declines both Q/Q and Y/Y. Despite this, NWSA's cost management led to a rise in EBITDA growth across all segments, except for News Media (-26% Y/Y). However, NWSA plans to address this through further cost cuts at the Daily Mail Group, News UK, and TalkTV. We are also encouraged by management's commentary regarding the potential restructuring of NWSA, in order to reduce its conglomerate discount. This development, along with its recent rental agreement with Zillow and its partnership extension with Google reaffirm our Buy view.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Apr 23, 2024
12:45 PM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price by $3 to $108, implying a 2024 P/E of 15.4x, largely in line with the peer average. Novartis ( NVS ) raised its full-year 2024...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Invesco Ltd.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Invesco Ltd.
Apr 23, 2024
10:45 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We trim our 12-month target by $2 to $16, valuing IVZ shares at 8.6x our 2025 adjusted EPS estimate of $1.85 (cut today by $0.05) and at 10x our 2024...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Msci Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Msci Inc.
Apr 23, 2024
11:40 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We decrease our target price by $165 to $465, 27.4x our 2025 EPS estimate, a discount to MSCI's ( MSCI ) 10-year forward P/E average of 36.4x given reduced growth...
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Jetblue Airways Corporation
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Jetblue Airways Corporation
Apr 23, 2024
11:45 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target of $6.50, down $0.50, reflects a 3.4x multiple of EV to projected '25 EBITDA, a discount to JBLU's historical average. We think a discount is merited due...
Copyright 2023-2026 - www.financetom.com All Rights Reserved